FREE SHIPPING ON ORDERS OVER $150

glutathione cancer ncbi and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Efficacy of glutathione inhibitor eprenetapopt

$29.47

Quantity
- +
Description

Cerevisiae in E

glutathione cancer ncbi and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Efficacy of glutathione inhibitor eprenetapopt

Visser WR, Smith-Harrison LI, Krzastek SC

glutathione cancer ncbi and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Efficacy of glutathione inhibitor eprenetapopt

The bands and specific antibodies (all 1:1000 dilutions) (Additional file 2: Table S1) used were: H3K9me3 (A2360, Abclonal, Woburn, MA), H3K27me3 (A2363, Abclonal), H3K9me1 (A2358, Abclonal), H3K27me1 (A2361, Abclonal), H3 (A2348, Abclonal), -catenin (8480, CST), transcription factor 4 (TCF4) (2569, Cell Signaling Technology), secreted frizzled related protein 1 (SFRP1) (A2911, Abclonal), RPL15 (A3241, Abclonal), and -actin (AC026, Abclonal)

glutathione cancer ncbi and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Efficacy of glutathione inhibitor eprenetapopt

Pathological increases in local concentrations of ROS cause oxidative stress (102)

glutathione cancer ncbi and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Efficacy of glutathione inhibitor eprenetapopt

& Herrmann, W

glutathione cancer ncbi and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Efficacy of glutathione inhibitor eprenetapopt

48280, Puerto Vallarta, Jalisco, Mxico Corresponding Author: Erandis Dheni Torres Sanchez, PhD Departmento de Ciencias Mdicas y de la Vida Centro Universitario de la Cinega Universidad de Guadalajara (CUCI-UdeG) Av

glutathione cancer ncbi and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Efficacy of glutathione inhibitor eprenetapopt

You may also like

recommand products